Latest Insider Transactions at Encompass Health Corp (EHC)
This section provides a real-time view of insider transactions for Encompass Health Corp (EHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Encompass Health Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Encompass Health Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 17
2023
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
99
+0.24%
|
-
|
|
Apr 17
2023
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.25%
|
-
|
|
Apr 17
2023
|
Donald L Correll Director |
BUY
Grant, award, or other acquisition
|
Direct |
233
+0.24%
|
-
|
|
Apr 17
2023
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.21%
|
-
|
|
Feb 27
2023
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
509
-0.67%
|
$30,540
$60.22 P/Share
|
|
Feb 27
2023
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
410
-0.56%
|
$24,600
$60.22 P/Share
|
|
Feb 27
2023
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,895
-0.58%
|
$173,700
$60.22 P/Share
|
|
Feb 27
2023
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
383
-0.39%
|
$22,980
$60.22 P/Share
|
|
Feb 27
2023
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,078
-0.96%
|
$64,680
$60.22 P/Share
|
|
Feb 27
2023
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
506
-1.59%
|
$30,360
$60.22 P/Share
|
|
Feb 24
2023
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
397
-0.52%
|
$23,820
$60.22 P/Share
|
|
Feb 24
2023
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
320
-0.44%
|
$19,200
$60.22 P/Share
|
|
Feb 24
2023
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,256
-0.45%
|
$135,360
$60.22 P/Share
|
|
Feb 24
2023
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
299
-0.3%
|
$17,940
$60.22 P/Share
|
|
Feb 24
2023
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
840
-0.74%
|
$50,400
$60.22 P/Share
|
|
Feb 24
2023
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
356
-1.1%
|
$21,360
$60.22 P/Share
|
|
Feb 23
2023
|
Douglas E Coltharp EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,488
+24.17%
|
-
|
|
Feb 23
2023
|
Mark J Tarr President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
78,327
+7.24%
|
-
|
|
Feb 23
2023
|
Elissa Joy Charbonneau Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,881
+11.4%
|
-
|
|
Feb 23
2023
|
John Patrick Darby EVP, Gen Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
28,527
+17.27%
|
-
|
|
Feb 23
2023
|
Andrew L Price Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,114
+4.73%
|
-
|
|
Feb 23
2023
|
Edmund Fay Sr. Vice Pres. and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
6,688
+3.32%
|
-
|
|
Feb 21
2023
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
278
-0.3%
|
$17,236
$62.86 P/Share
|
|
Feb 21
2023
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
782
-1.47%
|
$48,484
$62.86 P/Share
|
|
Feb 21
2023
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,100
-0.49%
|
$130,200
$62.86 P/Share
|
|
Feb 21
2023
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
332
-1.34%
|
$20,584
$62.86 P/Share
|
|
Feb 21
2023
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
369
-0.77%
|
$22,878
$62.86 P/Share
|
|
Feb 21
2023
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
298
-0.45%
|
$18,476
$62.86 P/Share
|
|
Feb 10
2023
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,895
-25.21%
|
$1,073,700
$60.78 P/Share
|
|
Feb 10
2023
|
Douglas E Coltharp EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,895
+20.13%
|
$357,900
$20.07 P/Share
|
|
Jan 17
2023
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.24%
|
-
|
|
Jan 17
2023
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
37
+0.25%
|
-
|
|
Jan 17
2023
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.21%
|
-
|
|
Jan 17
2023
|
Donald L Correll Director |
BUY
Grant, award, or other acquisition
|
Direct |
233
+0.24%
|
-
|
|
Jan 17
2023
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.13%
|
$480
$30.75 P/Share
|
|
Jan 17
2023
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.25%
|
-
|
|
Jan 17
2023
|
Kevin J. O'Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.2%
|
-
|
|
Jan 17
2023
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
99
+0.24%
|
-
|
|
Jan 17
2023
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
906
+0.29%
|
$27,180
$30.83 P/Share
|
|
Jan 17
2023
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
99
+0.24%
|
-
|
|
Jan 03
2023
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,449
-10.83%
|
$380,491
$59.81 P/Share
|
|
Jan 03
2023
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,576
-3.31%
|
$859,984
$59.81 P/Share
|
|
Jan 03
2023
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,477
-5.64%
|
$87,143
$59.81 P/Share
|
|
Jan 03
2023
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,259
-1.34%
|
$74,281
$59.81 P/Share
|
|
Jan 03
2023
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,113
-6.11%
|
$183,667
$59.81 P/Share
|
|
Jan 03
2023
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,344
-1.99%
|
$79,296
$59.81 P/Share
|
|
Oct 31
2022
|
Greg D Carmichael Director |
BUY
Open market or private purchase
|
Direct |
1,830
+14.79%
|
$98,820
$54.67 P/Share
|
|
Oct 18
2022
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
507
+7.69%
|
$24,843
$49.7 P/Share
|
|
Oct 18
2022
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
848
+0.54%
|
$41,552
$49.73 P/Share
|
|
Oct 17
2022
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.23%
|
-
|